| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |